Skip to main content
SpringerLink
Log in

Ouderdomsmaculadegeneratie

  • Artikel
  • Published:
Bijblijven

Samenvatting

Ouderdomsmaculadegeneratie is een belangrijke oogziekte. Vroegtijdige onderkenning, snelle verwijzing bij suspecte symptomen en preventieve maatregelen bij de aanwezigheid van vroege kenmerken kunnen het aantal slechtzienden door ouderdomsmaculadegeneratie terugdringen. Behandeling is in de meeste gevallen nog niet goed mogelijk, maar nieuwe ontwikkelingen op dit gebied geven hoop op betere behandelmethodes in de nabije toekomst.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatuur

  • Kuhnt PJP. Die scheibenförmige Entartung der Netzhautmitte. Berlin: Karger, 1926.

    Google Scholar 

  • Kini MM, Leibowitz HM, Colton T, Nickerson RJ, Ganley J, Dawber TR. Prevalence of senile cataract, diabetic retinopathy, senile macular degeneration, and open-angle glaucoma in the Framingham eye study. Am J Ophthalmol 1978;85:28-34.

    CAS  PubMed  Google Scholar 

  • Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, et al. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 1980;24(Suppl):335-610.

    Article  CAS  PubMed  Google Scholar 

  • Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:933-43.

    CAS  Google Scholar 

  • Mitchell P, Smith W, Attebo K, Wang JJ. Prevalence of age-related maculopathy in Australia: The Blue Mountains Eye Study. Ophthalmology 1995;102:1450-60.

    CAS  PubMed  Google Scholar 

  • Vingerling JR, Dielemans I, Hofman A, Grobbee DE, Hijmering M, Kramer CF, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995;102:205-10.

    CAS  PubMed  Google Scholar 

  • Leeuwen R van, Klaver CC, Vingerling JR, Hofman A, Jong PT de. Epidemiology of age-related maculopathy: A review. Eur J Epidemiol 2003;18:845-54.

    Article  PubMed  Google Scholar 

  • Holz FG, Pauleikhoff D, Klein R, Bird AC. Pathogenesis of lesions in late age-related macular disease. Am J Ophthalmol 2004;137:504-10.

    Article  PubMed  Google Scholar 

  • Blumenkranz MS, Russell SR, Robey MG, Kott-Blumenkranz R, Penneys N. Risk factors in age-related maculopathy complicated by choroidal neovascularization. Ophthalmology 1986;93:552-8.

    CAS  PubMed  Google Scholar 

  • Hyman LG, Lilienfeld AM, Ferris 3rd FL, Fine SL. Senile macular degeneration: A case-control study. Am J Epidemiol 1983;118:213-27.

    CAS  Google Scholar 

  • Klein R, Klein BE, Linton KL, DeMets DL. The Beaver Dam Eye Study: The relation of age-related maculopathy to smoking. Am J Epidemiol 1993;137:190-200.

    CAS  PubMed  Google Scholar 

  • Paetkau ME, Boyd TA, Grace M, Bach-Mills J, Winship B. Senile disciform macular degeneration and smoking. Can J Ophthalmol 1978;13:67-71.

    CAS  PubMed  Google Scholar 

  • Seddon JM, Willett WC, Speizer FE, Hankinson SE. A prospective study of cigarette smoking and age-related macular degeneration in women.jama 1996;276:1141-6.

    Article  CAS  PubMed  Google Scholar 

  • Vingerling JR, Hofman A, Grobbee DE, Jong PT de. Age-related macular degeneration and smoking: The Rotterdam Study. Arch Ophthalmol 1996;114:1193-6.

    CAS  PubMed  Google Scholar 

  • Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-related macular degeneration. Am J Ophthalmol 2004;137:486-95.

    Article  PubMed  Google Scholar 

  • Thornton J, Edwards R, Mitchell P, Harrison RA, Buchan I, Kelly SP. Smoking and age-related macular degeneration: A review of association. Eye 2005;19:935-44.

    Article  CAS  PubMed  Google Scholar 

  • Tomany SC, Wang JJ, Leeuwen R van, Klein R, Mitchell P, Vingerling JR, et al. Risk factors for incident age-related macular degeneration: Pooled findings from 3 continents. Ophthalmology 2004;111:1280-7.

    Article  PubMed  Google Scholar 

  • Hageman GS, Anderson DH, Johnson LV, Hancox LS, Taiber AJ, Hardisty LI, et al. A common haplotype in the complement regulatory gene factor H (hf1/cfh) predisposes individuals to age-related macular degeneration. Proc Natl Acad Sciusa 2005;102:7227-32.

    Article  CAS  PubMed  Google Scholar 

  • Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005;308:385-9.

    Article  CAS  PubMed  Google Scholar 

  • Seddon JM, Gensler G, Milton RC, Klein ML, Rifai N. Association between C-reactive protein and age-related macular degeneration.jama 2004;291:704-10.

    Article  CAS  PubMed  Google Scholar 

  • Seddon JM, George S, Rosner B, Rifai N. Progression of age-related macular degeneration: Prospective assessment of C-reactive protein, interleukin 6, and other cardiovascular biomarkers. Arch Ophthalmol 2005;123:774-82.

    Article  PubMed  Google Scholar 

  • A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss:areds report no. 8. Arch Ophthalmol 2001;119:1417-36.

  • Leeuwen R van, Boekhoorn S, Vingerling JR, Witteman JC, Klaver CC, Hofman A, et al. Dietary intake of antioxidants and risk of age-related macular degeneration.jama 2005;294:3101-7.

    Article  PubMed  Google Scholar 

  • Christen WG, Glynn RJ, Ajani UA, Schaumberg DA, Chew EY, Buring JE, et al. Age-related maculopathy in a randomized trial of low-dose aspirin amongus physicians. Arch Ophthalmol 2001;119:1143-9.

    CAS  PubMed  Google Scholar 

  • Brown GC, Tasman WS, Shields JA. Massive subretinal hemorrhage and anticoagulant therapy. Can J Ophthalmol 1982;17:227-30.

    CAS  PubMed  Google Scholar 

  • Tilanus MA, Vaandrager W, Cuypers MH, Verbeek AM, Hoyng CB. Relationship between anticoagulant medication and massive intraocular hemorrhage in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 2000;238:482-5.

    Article  CAS  PubMed  Google Scholar 

  • Bressler NM, Frost LA, Bressler SB, Murphy RP, Fine SL. Natural course of poorly defined choroidal neovascularization associated with macular degeneration. Arch Ophthalmol 1988;106:1537-42.

    CAS  PubMed  Google Scholar 

  • Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study. Macular Photocoagulation Study Group. Arch Ophthalmol 1991;109:1242-57.

  • Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials–tap report: Treatment of age-related macular degeneration with photodynamic therapy (tap) Study Group. Arch Ophthalmol 1999;117:1329-45.

  • Witmer AN, Vrensen GF, Noorden CJ van, Schlingemann RO. Vascular endothelial growth factors and angiogenesis in eye disease. Prog Retin Eye Res 2003;22:1-29.

    Article  CAS  PubMed  Google Scholar 

  • D’Amico DJ, Goldberg MF, Hudson H, Jerdan JA, Krueger DS, Luna SP, et al. Anecortave acetate as monotherapy for treatment of subfoveal neovascularization in age-related macular degeneration: Twelve-month clinical outcomes. Ophthalmology 2003;110:2372-83; discussion 2384-5.

    Article  PubMed  Google Scholar 

  • Gragoudas ES, Adamis AP, Cunningham ET Jr., Feinsod M, Guyer DR. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004;351:2805-16.

    Article  CAS  PubMed  Google Scholar 

  • Rosenfeld PJ, Heier JS, Hantsbarger G, Shams N. Tolerability and efficacy of multiple escalating doses of ranibizumab (Lucentis) for neovascular age-related macular degeneration. Ophthalmology 2006;113:632.e1.

    Article  Google Scholar 

  • Heier JS, Antoszyk AN, Pavan PR, Leff SR, Rosenfeld PJ, Ciulla TA, et al. Ranibizumab for treatment of neovascular age-related macular degeneration: A phase I/II multicenter, controlled, multidose study. Ophthalmology 2006;113:642.e1-4.

    Google Scholar 

  • Rosenfeld PJ, Moshfeghi AA, Puliafito CA. Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration. Ophthalmic Surg Lasers Imaging 2005;36:331-5.

    PubMed  Google Scholar 

  • Spaide RF, Laud K, Fine HF, Klancnik JM Jr., Meyerle CB, Yannuzzi LA, et al. Intravitreal bevacizumab treatment of choroidal neovascularization secondary to age-related macular degeneration. Retina 2006;26:383-90.

    Article  PubMed  Google Scholar 

  • Machemer R. Macular translocation. Am J Ophthalmol 1998;125:698-700.

    Article  CAS  PubMed  Google Scholar 

  • Pertile G, Claes C. Macular translocation with 360 degree retinotomy for management of age-related macular degeneration with subfoveal choroidal neovascularization. Am J Ophthalmol 2002;134:560-5.

    Article  PubMed  Google Scholar 

  • Meurs JC van, Biesen PR van den. Autologous retinal pigment epithelium and choroid translocation in patients with exudative age-related macular degeneration: Short-term follow-up. Am J Ophthalmol 2003;136:688-95.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. www.bijblijven.bsl.nl

    H. Vingerling

Authors
  1. H. Vingerling
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Dr. H. Vingerling, oogarts, Erasmusmc, Rotterdam.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Vingerling, H. Ouderdomsmaculadegeneratie. BIJB 22, 155–159 (2006). https://doi.org/10.1007/BF03059929

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03059929

Search

Navigation